Strategy
Discover what institutional investors prioritise when pitching stocks, straight from the Sohn Hearts & Minds conference. Learn how to tailor your story to resonate with instos and position your company for long-term growth in 2025.
Strategy
Hey everyone – I’m Hannah! I joined InvestorHub three months ago, and it’s been an exciting journey so far! My first task here is taking over the community dinners, and it’s been such a great experience. In just the first few weeks, I’ve attended seven events and
Strategy
I spoke with a few full time (aka professional) investors this week, and was reminded of a simple truth from long ago: Investing is a lonely job. I’m not talking about investment bankers who hunt in packs, or brokers and advisers parading as actual investors. I am talking about
Strategy
The ASX doesn’t owe you anything, but it offers opportunity if you own your listing. Discover how one company's journey highlights the importance of driving your own market engagement.
Strategy
After two tough years, the market is showing signs of life. But is this upswing here to stay, or just a temporary bounce? Dive into the latest data and see what it could mean for public companies on the ASX.
Strategy
It's a popular belief that investors only care about the dollars and cents, but for today’s article I am here with more InvestorHub data to show you that this is not the case. Ok - so some background information for context. 1. I run InvestorHub, a new
Strategy
Being a public company is tough, but it might still beat staying private. Data shows public companies enjoy more capital, higher survival rates, and greater resilience than private firms.
Strategy
Since we first published this article, we have had to correct some original data. 56%, not 63%, of the source of buying volume over the prior three months had come from existing shareholders. The article has been edited accordingly, and you can read about our more comprehensive analysis here, which
Strategy
How to build shareholder loyalty. If you want to be treated like a real company—not just another code—then it’s time to start treating your shareholders like actual people, not numbers. I’ve talked to hundreds of ASX leaders, and every single one says the same thing: “We
Strategy
Meet Dr Daniel Tillett. In late 2019, Dr Daniel Tillett, a biotech expert and investor, joined the board of Race Oncology. Despite expectations of a discount raise, he did something different: he invested at a premium. Since then, he’s raised $30m in a shareholder-driven round and never sold a
Strategy
Last week, we explored the “winner takes all” dynamic that’s come to define the ASX in 2024. This week, let’s dive into one of the key drivers behind that phenomenon—ETFs— the powerful tailwinds they’re creating for ASX200 companies and the implications for small and micro caps.
Strategy
This week, the AFR published an article that touted the claim that, at least in 2024, the ASX is a “winner takes all” environment. Within the article, it argues that, with the recent flatlining of ASX200 stocks, the small cap market has no chance of a revival. Or in other